OBJECTIVE: The study analyzed 3359 consecutive renal transplant operations for patient and graft survival, including living related, cadaveric, and living unrelated patients. The analysis was separated into three groups according to immunosuppression and date of transplant. SUMMARY BACKGROUND DATA: Improvements in renal transplantation in the past 25 years have been the result of better immunosuppression, organ preservation, and patient selection. METHODS: A single transplant center's experience over a 25-year period was analyzed regarding patient and graft survival. Potential risk factors included patient demographics, tissue typing, donor characteristics, number of transplants, acute and chronic rejection, acute tubular necrosis, primary disease, and malignancy. RESULTS: The primary cause of graft loss was rejection. Improvement in cadaveric graft survival since 1987 with quadruple therapy was not apparent in living donor patients. Race continued to be a negative factor in graft survival. Avoiding previous mismatched antigens and the use of flow cytometry improved allograft survival. The leading cause of death in the past 7 years in cadaveric recipients was cardiac (52%). CONCLUSIONS: Improved graft survival in the past 25 years was related to 1) advances in immunosuppression, 2) better methods of cytotoxic antibody detection, and 3) human lymphocyte antigen match.
OBJECTIVE: The study analyzed 3359 consecutive renal transplant operations for patient and graft survival, including living related, cadaveric, and living unrelated patients. The analysis was separated into three groups according to immunosuppression and date of transplant. SUMMARY BACKGROUND DATA: Improvements in renal transplantation in the past 25 years have been the result of better immunosuppression, organ preservation, and patient selection. METHODS: A single transplant center's experience over a 25-year period was analyzed regarding patient and graft survival. Potential risk factors included patient demographics, tissue typing, donor characteristics, number of transplants, acute and chronic rejection, acute tubular necrosis, primary disease, and malignancy. RESULTS: The primary cause of graft loss was rejection. Improvement in cadaveric graft survival since 1987 with quadruple therapy was not apparent in living donorpatients. Race continued to be a negative factor in graft survival. Avoiding previous mismatched antigens and the use of flow cytometry improved allograft survival. The leading cause of death in the past 7 years in cadaveric recipients was cardiac (52%). CONCLUSIONS: Improved graft survival in the past 25 years was related to 1) advances in immunosuppression, 2) better methods of cytotoxic antibody detection, and 3) human lymphocyte antigen match.
Authors: D O McDaniel; J Naftilan; K Hulvey; S Shaneyfelt; J A Lemons; S Lagoo-Deenadayalan; S Hudson; A G Diethelm; W H Barber Journal: Transplantation Date: 1994-03-27 Impact factor: 4.939
Authors: R Y Calne; D J White; S Thiru; D B Evans; P McMaster; D C Dunn; G N Craddock; B D Pentlow; K Rolles Journal: Lancet Date: 1978 Dec 23-30 Impact factor: 79.321
Authors: P Fontes; A S Rao; A J Demetris; A Zeevi; M Trucco; P Carroll; W Rybka; W A Rudert; C Ricordi; F Dodson Journal: Lancet Date: 1994-07-16 Impact factor: 79.321
Authors: Douglas E Schaubel; John R Jeffery; Yang Mao; Robert Semenciw; Karen Yeates; Stanley S A Fenton Journal: CMAJ Date: 2002-07-23 Impact factor: 8.262
Authors: F Perner; J Járay; F Alföldy; M Hídvégi; K Darvas; D Görög; A Tóth; T Gondos; E Toronyi; G Petrányi Journal: Surg Today Date: 1996 Impact factor: 2.549
Authors: Ye Na Kim; Do Hyoung Kim; Ho Sik Shin; Sangjin Lee; Nuri Lee; Min-Jeong Park; Wonkeun Song; Seri Jeong Journal: PLoS One Date: 2020-12-10 Impact factor: 3.240